Work

Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

Year: 2016

Type: article

Abstract: A common criticism of the pharmaceutical industry is that it fails to achieve transparency [ 1 , 2 ]. To allay concerns, the industry needs to collaborate openly with stakeholders to make medicines widely available and affordable—this will mean companies need to address some of their practices [ 1 , 3 , 4 ]. We suggest that an important practice to address is the presentation of health economic models.

Source: PharmacoEconomics

DOI: 10.1007/s40273-016-0479-8

Authors: William C. N. Dunlop, Nicola Mason, James Kenworthy, Ron L. Akehurst

Institutions: Mundipharma (United Kingdom), BresMed

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

Open Access status: hybrid

Estimated APC paid: $4,990

Funder: Mundipharma International